These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 3769388
1. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer. Haegele KD, Schechter PJ. Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388 [Abstract] [Full Text] [Related]
8. Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure. Jacqz-Aigrain E, Guillonneau M, Rey E, Macher MA, Montes C, Chiron C, Loirat C. Br J Clin Pharmacol; 1997 Aug; 44(2):183-5. PubMed ID: 9278207 [Abstract] [Full Text] [Related]
11. Inhibition of the enzyme, GABA-aminotransferase in human platelets by vigabatrin, a potential antiepileptic drug. Rimmer E, Kongola G, Richens A. Br J Clin Pharmacol; 1988 Feb; 25(2):251-9. PubMed ID: 3358887 [Abstract] [Full Text] [Related]
12. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects. Lorier M, Magallanes L, Ibarra M, Guevara N, Vázquez M, Fagiolino P. Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950 [Abstract] [Full Text] [Related]
14. Influence of the route of administration on the pharmacokinetics of pirprofen enantiomers in the rat. Brocks DR, Liang WT, Jamali F. Chirality; 1993 Dec; 5(2):61-4. PubMed ID: 8343343 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats. Zheng Q, He S, Xu SL, Ma MD, Fan M, Ge JF. Saudi Pharm J; 2024 Feb; 32(2):101934. PubMed ID: 38223203 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of the enantiomers of acenocoumarol in man. Godbillon J, Richard J, Gerardin A, Meinertz T, Kasper W, Jähnchen E. Br J Clin Pharmacol; 1981 Nov; 12(5):621-9. PubMed ID: 7332726 [Abstract] [Full Text] [Related]